Amino acid intolerance during prolonged total parenteral nutrition reversed by molybdate therapy.
D000328:Adult; D000596:Amino Acids / Q000009:adverse effects*; D003553:Cystine / Q000097:blood; D006801:Humans; D007042:Hypoxanthines / Q000652:urine; D008297:Male; D008715:Methionine / Q000009:adverse effects / Q000097:blood; D008982:Molybdenum / Q000627:therapeutic use*; D010288:Parenteral Nutrition / Q000009:adverse effects*; D010289:Parenteral Nutrition, Total / Q000009:adverse effects*; D013431:Sulfates / Q000652:urine; D013447:Sulfites / Q000652:urine; D013654:Taurine / Q000097:blood; D014527:Uric Acid / Q000097:blood / Q000652:urine; D014970:Xanthines / Q000652:urine
D000596:Amino Acids; D007042:Hypoxanthines; D013431:Sulfates; D013447:Sulfites; D014970:Xanthines; D013654:Taurine; D014527:Uric Acid; D003553:Cystine; D008982:Molybdenum; D008715:Methionine; C022175:ammonium molybdate